Generic Makers: Economics, Not Foreign Production, Causing Drug Shortages

By Jessica Karins / February 7, 2024 at 6:24 PM
TAMPA, FL -- Manufacturers of generic drugs are concerned that a focus in Congress on quality issues with drugs manufactured overseas and FDA’s low numbers of foreign inspections may overshadow what they view as the main factors leading to generic drug shortages, which they say are economic issues related to overly low prices. At the Association for Accessible Medicines (AAM) annual meeting in Tampa, FL this week, officials with the generics and biosimilars lobbying group told Inside Health Policy...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.